p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage

Published:2010-08-06 Issue:2 Volume:18 Page:248-258
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Aoubala M,Murray-Zmijewski F,Khoury M P,Fernandes K,Perrier S,Bernard H,Prats A-C,Lane D P,Bourdon J-C

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/cdd201091.pdf

Reference31 articles.

1. Royds JA, Iacopetta B . p53 and disease: when the guardian angel fails. Cell Death Differ 2006; 13: 1017–1026.

2. Braithwaite AW, Prives CL . p53: more research and more questions. Cell Death Differ 2006; 13: 877–880.

3. Vousden KH, Lane DP . p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8: 275–283.

4. Lavin MF, Gueven N . The complexity of p53 stabilization and activation. Cell Death Differ 2006; 13: 941–950.

5. Laptenko O, Prives C . Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 2006; 13: 951–961.

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss of Dnajc21 leads to cytopenia and altered nucleotide metabolism in zebrafish;Leukemia;2024-08-13

2. Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance;Cell Death & Disease;2024-06-12

3. Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α;Proceedings of the National Academy of Sciences;2024-02-26

4. Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for different molecular types of breast cancer;British Journal of Cancer;2024-02-14

5. The Important Role of Protein Kinases in the p53 Sestrin Signaling Pathway;Cancers;2023-11-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3